◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

New China Life Insurance Company Ltd. (1336) Net Income 2021–2025

Name: New China Life Insurance Company Ltd. (1336) net income history 2021-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-11

New China Life Insurance Company Ltd. annual net income for fiscal 2025 was CNY 36.3 billion, an increase of 38.3% from CNY 26.2 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

1336 Annual Net Income

Net Income (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Net Income	CNY 36.3B	CNY 26.2B	CNY 8.7B	CNY 21.5B	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

1336 Quarterly Net Income

Net Income (quarterly)	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Net Income	CNY 6.5B	CNY 3.4B	CNY 8.9B	CNY 5.9B	CNY 5.5B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

1299 Net Income — AIA Group Limited
0945 Net Income — Manulife Financial Corporation
2601 Net Income — China Pacific Insurance (Group) Co., Ltd.
2378 Net Income — Prudential plc

More 1336 metrics: Revenue · EPS · Free Cash Flow

All 1336 financial statements → Interactive 1336 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.